Trifluoroacetic acid → (4-Bromo-2-fluorophenyl)[4-(3-chloro-5-methylpyridin-2-yl)piperazin-1-yl]methanone
Reaction equation
C(O[C:6]([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[C:19]([Cl:20])=[CH:18][C:17]([CH3:21])=[CH:16][N:15]=2)[CH2:10][CH2:9]1)=[O:7])(C)(C)C.FC(F)(F)C(O)=O.[OH-].[Na+].[Br:31][C:32]1[CH:40]=[CH:39][C:35](C(Cl)=O)=[C:34]([F:41])[CH:33]=1>C(Cl)(Cl)Cl>[Br:31][C:32]1[CH:40]=[CH:39][C:35]([C:6]([N:8]2[CH2:9][CH2:10][N:11]([C:14]3[C:19]([Cl:20])=[CH:18][C:17]([CH3:21])=[CH:16][N:15]=3)[CH2:12][CH2:13]2)=[O:7])=[C:34]([F:41])[CH:33]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
4-(3-Chloro-5-methylpyridin-2-yl)piperazine-1-carboxylic acid tert-butyl ester (1.4 g), which is the intermediate described in Preparation Example 48, was dissolved in chloroform (2.5 mL), trifluoroacetic acid (2 mL) was added, and the mixture was stirred at room temperature overnight. The reaction mixture was alkalified with 1N aqueous sodium hydroxide solution, and extracted with chloroform. The organic layer was washed with saturated brine, and the solvent was evaporated. By reaction and treatment in the same manner as in Preparation Example 8 and using the obtained residue and 4-bromo-2-fluorobenzoyl chloride (1.1 g), the title compound (1.9 g) was obtained.
Workup
- customdescribed in Preparation Example 48
- extractionextracted with chloroform
- washThe organic layer was washed with saturated brine
- customthe solvent was evaporated
- customBy reaction and treatment in the same manner
- customas in Preparation Example 8
Sources & evidence
- ORD record
- ord-b50f80faad024fe49aa2f14889088a26
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…